Humoral Immunology Core Laboratory for AIDS Vaccine Research
Award Notice Posted
- Solicitation number
- 75N93025C00006
- Agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Awarded
- to Duke University
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- 75N93025C00006 Federal contract award
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Place of performance
- Durham, North Carolina 27705, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services, has awarded a cost-reimbursement contract to Duke University for a Humoral Immunology Core Laboratory for AIDS Vaccine Research. The contract, valued at $28,340,062, was awarded on March 28, 2025, with a base performance period from March 30, 2025, through March 29, 2025, and a total potential performance period extending through March 29, 2032. The government selected a cost-reimbursement contract type due to the dynamic and science-responsive nature of the work, which requires flexibility in addressing evolving research requirements and cannot be precisely specified under a fixed-price contract. The contract was awarded following Solicitation #75N93023R00012 and will be performed at Duke University's School of Medicine in Durham, North Carolina.
Notice text
A competitive cost reimbursement, level of effort (term) type contract was awarded, for the period of performance of March 30, 2025 through March 29, 2025 (Base Period), and a total period of performance (including base period and all options) of March 30, 2025 through March 29, 2032. Upon analysis of the type of work and all associated costs involved, a fixed-price type contract was not feasible due to the absence of precise specifications and difficulties in estimating costs with accuracy. Based upon the uncertainties involved, the Government would assume undue risk in attempting to fit a relatively dynamic (science responsive and result-driven) requirement into a fixed-price environment. A fixed-price contract would be disadvantageous to the Government, since it does not provide the Government with the flexibility that is needed to responsibly shift with the evolving needs of the requirement.
The award notice is in relation to Solicitation # 75N93023R00012.
Awarded contract 75N93025C00006 to DUKE UNIVERSITY for 28340062.00 on 2025-03-28.
Files
| File | Type | Posted |
|---|---|---|
| Award Synopsis Duke.pdf |
Notice history
| Notice | Type | Posted |
|---|---|---|
| This notice | Award Notice | |
| Humoral Immunology Core Laboratory for AIDS Vaccine Research | Solicitation | |
| Humoral Immunology Core Laboratory for AIDS Vaccine Research | Pre-Solicitation |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Pre-Clinical Models of Infectious Diseases | National Institute of Allergy and Infectious Diseases | No set-aside | |
| 2027 NIAID DMID Omnibus Broad Agency Announcement: Development of Medical Interventions for Infectious Diseases | National Institute of Allergy and Infectious Diseases | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity